Disclaimer

This website contains material about Nestlé Health Science products. Nestlé provides this material for the information and education of Health Care Professionals. If you choose to view this material, you are accepting that:

  • You are a Health Care Professional.
  • This material is supplied at your individual request, for educational purposes.
  • This material does not substitute for, or replace, the advice of a qualified Health Care Professional.
  • The material is provided for professional use only and must not be used for any other purpose.

I AGREEI DON’T AGREE

Due to the biological basis of obesity some patients may require additional pharmacotherapy to assist in appetite suppression. OPTIFAST® VLCD™ may be used in conjunction with prescription medications to facilitate weight loss. Noradrenergic agonists (phentermine) have been used in conjunction with the OPTIFAST® VLCD™ Program, it is recommended that they are not used for a period of more than 3 months.

We don't recommend that other over the counter weight loss products or appetite suppressants be taken with OPTIFAST® VLCD™. There is currently no clinical evidence to support the efficacy and safety of using products such as these in conjunction with the OPTIFAST® VLCD™ Program.

About cookies on this site

Our site uses cookies and other technologies so that we, and our partners, can remember you and understand how you use our site. Further use of this site will be considered consent. For more information, visit our Privacy Policy.

I have read and understood the Nestlé Privacy Notice. Do not show this message again.
x